All Relations between Schizophrenia and Risperidone

Publication Sentence Publish Date Extraction Date Species
John J Spollen, Robert G Wooten, Christopher Cargile, George Bartztoki. Prolactin levels and erectile function in patients treated with risperidone. Journal of clinical psychopharmacology. vol 24. issue 2. 2004-07-06. PMID:15206663. we evaluated whether the prl elevations caused by risperidone treatment of subjects with schizophrenia are associated with objective measures of erectile function. 2004-07-06 2023-08-12 human
Zahid-Ul Hu. A trial of low doses of risperidone in the treatment of patients with first-episode schizophrenia, schizophreniform disorder, or schizoaffective disorder. Journal of clinical psychopharmacology. vol 24. issue 2. 2004-07-06. PMID:15206670. this uk multicenter, noncomparative, open-trial study assessed risperidone in 74 first-psychotic-episode patients (dsm-iv schizophrenia) treated with flexible doses. 2004-07-06 2023-08-12 Not clear
Jan Volavka, Pal Czobor, Karen Nolan, Brian Sheitman, Jean-Pierre Lindenmayer, Leslie Citrome, Joseph P McEvoy, Thomas B Cooper, Jeffrey A Lieberma. Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. Journal of clinical psychopharmacology. vol 24. issue 2. 2004-07-06. PMID:15206671. overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. 2004-07-06 2023-08-12 human
Catherine Loh, Susan G Leckband, Jonathan M Meyer, Eric Turne. Risperidone-induced retrograde ejaculation: case report and review of the literature. International clinical psychopharmacology. vol 19. issue 2. 2004-06-22. PMID:15076020. presented here is the case of a 51 year old male with schizophrenia who developed retrograde ejaculation on high dose risperidone therapy (8 mg/day) with prompt resolution of symptoms upon dose reduction. 2004-06-22 2023-08-12 Not clear
Rocco Zoccali, Maria Rosaria Muscatello, Diletta La Torre, Giovanni Malara, Andrea Canale, Domenico Crucitti, Concetta D'Arrigo, Edoardo Spin. Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia. Pharmacological research. vol 48. issue 4. 2004-06-16. PMID:12902213. lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia. 2004-06-16 2023-08-12 Not clear
Rocco Zoccali, Maria Rosaria Muscatello, Diletta La Torre, Giovanni Malara, Andrea Canale, Domenico Crucitti, Concetta D'Arrigo, Edoardo Spin. Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia. Pharmacological research. vol 48. issue 4. 2004-06-16. PMID:12902213. the effect of mirtazapine on steady-state plasma concentrations of the newer atypical antipsychotics clozapine, risperidone and olanzapine was investigated in 24 patients with chronic schizophrenia. 2004-06-16 2023-08-12 Not clear
Hsien-Yuan Lane, Cheng-Chieh Lin, Chiung-Hsien Huang, Yue-Cune Chang, Shih-Kuan Hsu, Wen-Ho Chan. Risperidone response and 5-HT6 receptor gene variance: genetic association analysis with adjustment for nongenetic confounders. Schizophrenia research. vol 67. issue 1. 2004-06-01. PMID:14741325. we found an association between the t-->c 267 polymorphism of the 5ht6 receptor gene and response to risperidone in 123 acutely ill schizophrenia inpatients after adjustment for confounders. 2004-06-01 2023-08-12 Not clear
Yung-Chieh Yen, For-Wey Lung, Mian-Yoon Chon. Adverse effects of risperidone and haloperidol treatment in schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 28. issue 2. 2004-05-28. PMID:14751424. adverse effects of risperidone and haloperidol treatment in schizophrenia. 2004-05-28 2023-08-12 Not clear
Jayme L Opolka, Karen L Rascati, Carolyn M Brown, P J Gibso. Ethnicity and prescription patterns for haloperidol, risperidone, and olanzapine. Psychiatric services (Washington, D.C.). vol 55. issue 2. 2004-05-27. PMID:14762239. this study examined whether ethnicity helped predict whether patients with schizophrenia were given a first- or a second-generation antipsychotic, haloperidol versus risperidone or olanzapine, and what type of second-generation antipsychotic was prescribed, risperidone or olanzapine, when other factors were controlled for. 2004-05-27 2023-08-12 Not clear
Henry A Nasrallah, Inge Duchesne, Angelika Mehnert, Carmela Janagap, Mariëlle Eerdeken. Health-related quality of life in patients with schizophrenia during treatment with long-acting, injectable risperidone. The Journal of clinical psychiatry. vol 65. issue 4. 2004-05-25. PMID:15119916. health-related quality of life in patients with schizophrenia during treatment with long-acting, injectable risperidone. 2004-05-25 2023-08-12 Not clear
Henry A Nasrallah, Inge Duchesne, Angelika Mehnert, Carmela Janagap, Mariëlle Eerdeken. Health-related quality of life in patients with schizophrenia during treatment with long-acting, injectable risperidone. The Journal of clinical psychiatry. vol 65. issue 4. 2004-05-25. PMID:15119916. we investigated the impact of treatment with long-acting, injectable risperidone versus placebo on health-related quality of life (hrqol) in patients with schizophrenia. 2004-05-25 2023-08-12 Not clear
Martin Dossenbach, Almila Erol, Mohand el Mahfoud Kessaci, Mostafa O Shaheen, Mohammed M Sunbol, Jason Boland, Andrew Hodge, Ruth A O'Halloran, Istvan Bitte. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol. The Journal of clinical psychiatry. vol 65. issue 3. 2004-05-20. PMID:15096069. effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (ic-soho) comparing olanzapine, quetiapine, risperidone, and haloperidol. 2004-05-20 2023-08-12 Not clear
Johanna van Bruggen, Jans Tijssen, Petrus Dingemans, Berthold Gersons, Donald Linsze. Symptom response and side-effects of olanzapine and risperidone in young adults with recent onset schizophrenia. International clinical psychopharmacology. vol 18. issue 6. 2004-05-19. PMID:14571154. symptom response and side-effects of olanzapine and risperidone in young adults with recent onset schizophrenia. 2004-05-19 2023-08-12 Not clear
Johanna van Bruggen, Jans Tijssen, Petrus Dingemans, Berthold Gersons, Donald Linsze. Symptom response and side-effects of olanzapine and risperidone in young adults with recent onset schizophrenia. International clinical psychopharmacology. vol 18. issue 6. 2004-05-19. PMID:14571154. the symptom response and side-effects of olanzapine and risperidone were compared in patients with recent onset schizophrenia. 2004-05-19 2023-08-12 Not clear
Leslie Citrome, Daniel E Casey, David G Daniel, Patricia Wozniak, Lisa D Kochan, Katherine A Trac. Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone. Psychiatric services (Washington, D.C.). vol 55. issue 3. 2004-05-13. PMID:15001730. adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone. 2004-05-13 2023-08-12 Not clear
Leslie Citrome, Daniel E Casey, David G Daniel, Patricia Wozniak, Lisa D Kochan, Katherine A Trac. Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone. Psychiatric services (Washington, D.C.). vol 55. issue 3. 2004-05-13. PMID:15001730. this study compared the specific antihostility effects of atypical antipsychotic monotherapy (olanzapine or risperidone) with that of combination treatment with divalproex sodium among patients with schizophrenia experiencing an acute psychotic episode. 2004-05-13 2023-08-12 Not clear
Baybars Veznedaroglu, Eyup Sabri Ercan, Bulent Kayahan, Azmi Varan, Erhan Bayrakta. Reduced short-term obsessive-compulsive symptoms in schizophrenic patients treated with risperidone: a single-blind prospective study. Human psychopharmacology. vol 18. issue 8. 2004-05-10. PMID:14696023. risperidone is a widely used agent as first-line treatment in schizophrenia with a favorable side-effect profile. 2004-05-10 2023-08-12 Not clear
Akihiro Takano, Tetsuya Suhara, Yoko Ikoma, Fumihiko Yasuno, Jun Maeda, Tetsuya Ichimiya, Yasuhiko Sudo, Makoto Inoue, Yoshiro Okub. Estimation of the time-course of dopamine D2 receptor occupancy in living human brain from plasma pharmacokinetics of antipsychotics. The international journal of neuropsychopharmacology. vol 7. issue 1. 2004-05-07. PMID:14764214. dopamine d2 receptor occupancies and plasma concentrations of risperidone were measured in five patients with schizophrenia using positron emission tomography with [11c]flb 457. 2004-05-07 2023-08-12 human
Sanjiv Gulati, Ashok N Singh, Sue E Librett. Successful risperidone rechallenge after blepharospasm in a patient with schizophrenia: 24-month follow-up. Journal of psychopharmacology (Oxford, England). vol 17. issue 4. 2004-05-07. PMID:14870960. successful risperidone rechallenge after blepharospasm in a patient with schizophrenia: 24-month follow-up. 2004-05-07 2023-08-12 Not clear
Norbert Müller, Markus Ulmschneider, Constanze Scheppach, Markus J Schwarz, Manfred Ackenheil, Hans-Jürgen Möller, Rudolf Gruber, Michael Riede. COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy. European archives of psychiatry and clinical neuroscience. vol 254. issue 1. 2004-05-06. PMID:14991374. additional treatment with celecoxib has significant positive effects on the therapeutic action of risperidone with regard to the total schizophrenia psychopathology. 2004-05-06 2023-08-12 Not clear